Revelation Enterprise Value Over E B I T D A from 2010 to 2024
| REVBW Stock | USD 0.01 0.0001 0.81% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 89.98341526 | Current Value 94.48 | Quarterly Volatility 11.9 K |
Check Revelation Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revelation Biosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 7 M, Total Operating Expenses of 7 M or Total Other Income Expense Net of 9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.54. Revelation financial statements analysis is a perfect complement when working with Revelation Biosciences Valuation or Volatility modules.
Revelation | Enterprise Value Over E B I T D A |
Latest Revelation Biosciences' Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Revelation Biosciences over the last few years. It is Revelation Biosciences' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revelation Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Revelation Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (16,291) | |
| Geometric Mean | 2,394 | |
| Coefficient Of Variation | (72.82) | |
| Mean Deviation | 10,804 | |
| Median | (24,394) | |
| Standard Deviation | 11,863 | |
| Sample Variance | 140.7M | |
| Range | 24.5K | |
| R-Value | 0.82 | |
| Mean Square Error | 49.6M | |
| R-Squared | 0.67 | |
| Significance | 0.0002 | |
| Slope | 2,176 | |
| Total Sum of Squares | 2B |
Revelation Enterprise Value Over E B I T D A History
About Revelation Biosciences Financial Statements
Revelation Biosciences investors use historical fundamental indicators, such as Revelation Biosciences' Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revelation Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 89.98 | 94.48 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.